EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+10.93%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$6.37B
AUM Growth
+$6.37B
(+4.1%)
Cap. Flow
+$9.1M
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
24.31%
Holding
176
New
24
Increased
63
Reduced
39
Closed
19
Top Buys
| 1 |
Old Dominion Freight Line
ODFL
|
$71.8M |
| 2 |
Trade Desk
TTD
|
$42.2M |
| 3 |
Copart
CPRT
|
$41.3M |
| 4 |
GitLab
GTLB
|
$40.6M |
| 5 |
Rollins
ROL
|
$39.5M |
Top Sells
| 1 |
CrowdStrike
CRWD
|
$80M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$60.1M |
| 3 |
Palo Alto Networks
PANW
|
$57.7M |
| 4 |
Cheniere Energy
LNG
|
$51.4M |
| 5 |
BILL Holdings
BILL
|
$42.7M |
Sector Composition
| 1 | Healthcare | 38.58% |
| 2 | Technology | 26.06% |
| 3 | Industrials | 16.52% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Communication Services | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Inspire Medical Systems
INSP
$2.63B
| $26.9M | 0.42% |
125,090
| – | – |
|
77
Vistra
VST
$63.2B
| $26M | 0.41% |
372,861
+79,954
| +27% | +$5.57M |
|
78
Workday
WDAY
$62B
| $25.8M | 0.4% |
94,551
+87
| +0.1% | +$23.7K |
|
79
4D Molecular Therapeutics
FDMT
$293M
| $24.7M | 0.39% |
+776,114
| New | +$24.7M |
|
|
INZY
80
DELISTED
Inozyme Pharma
INZY
| $24.4M | 0.38% |
3,179,837
| – | – |
|
81
Krystal Biotech
KRYS
$4.36B
| $24.3M | 0.38% |
136,485
| – | – |
|
82
Steris
STE
$23.7B
| $22.2M | 0.35% |
98,873
| – | – |
|
83
BridgeBio Pharma
BBIO
$9.87B
| $22.2M | 0.35% |
716,927
| – | – |
|
84
Novanta
NOVT
$4B
| $22.1M | 0.35% |
126,359
+339
| +0.3% | +$59.2K |
|
|
BPMC
85
DELISTED
Blueprint Medicines
BPMC
| $22M | 0.34% |
231,685
-80,689
| -26% | -$7.65M |
|
86
Biohaven
BHVN
$1.75B
| $21.9M | 0.34% |
401,101
| – | – |
|
87
Repligen
RGEN
$6.73B
| $21.9M | 0.34% |
119,000
| – | – |
|
88
Remitly
RELY
$3.93B
| $21.3M | 0.33% |
+1,028,678
| New | +$21.3M |
|
|
MRNS
89
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $21.2M | 0.33% |
2,346,526
-2,183,471
| -48% | -$19.7M |
|
90
Royalty Pharma
RPRX
$15.7B
| $21M | 0.33% |
690,687
+156,712
| +29% | +$4.76M |
|
91
Viking Therapeutics
VKTX
$3.12B
| $20.7M | 0.33% |
252,969
-497,031
| -66% | -$40.8M |
|
|
CERE
92
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $20.7M | 0.32% |
490,000
| – | – |
|
93
Mobileye
MBLY
$11.3B
| $20.3M | 0.32% |
+631,379
| New | +$20.3M |
|
94
Aptiv
APTV
$17.4B
| $20M | 0.31% |
250,675
-534,798
| -68% | -$42.6M |
|
95
Iron Mountain
IRM
$26.5B
| $19.9M | 0.31% |
+247,702
| New | +$19.9M |
|
96
Bruker
BRKR
$4.47B
| $19.8M | 0.31% |
210,362
-3
| -0% | -$282 |
|
97
Privia Health
PRVA
$2.85B
| $19.6M | 0.31% |
1,000,000
| – | – |
|
98
Element Solutions
ESI
$6.11B
| $18.4M | 0.29% |
737,915
-44,410
| -6% | -$1.11M |
|
99
Cytokinetics
CYTK
$5.77B
| $17.8M | 0.28% |
254,148
-301,852
| -54% | -$21.2M |
|
|
RCM
100
DELISTED
R1 RCM Inc. Common Stock
RCM
| $17.7M | 0.28% |
1,375,980
| – | – |
|